Intracavernosal PGE1-related penile ®brosis: possible mechanisms.
1
We reported 2 a 10% incidence of distal penile ®brosis following long-term use of i.c. PGE1. In this study, this complication was not related to the injection site as the lesions occurred distally. Since these patients achieved a grade IV erection lasting between 1±2 h, the development of ®brosis could not have been associated with inadequate erections. To explain why our patients developed distal penile ®brosis, we suggest two mechanisms.
Firstly, it is well known that with aging there is signi®cant reduction of elastic ®bers in both layers of the tunica albuginea.
3 As a result, there is a signi®cant decrease in the elasticity of both the inner and septal ®brous layers supporting the tunica albuginea. Reduction in elastic ®bres and its elasticity prevents the corpora from tolerating relatively high i.c. pressures during PGE1-induced erections. This may result in tunical tears, disruption of small blood vessels, bleeding and clot formation. This could subsequently result in ®bro-sis.
Secondly, an ischaemic injury to the tunica albuginea may be involved in distal penile ®brosis. Assessment of blood¯ow by duplex sonography has shown a signi®cant reduction in the blood¯ow velocity in a proximo-distal direction following i.c. vasoactive injections. 4 Furthermore, the cavernous oxygen tension is signi®cantly lower after i.c. injection of PGE1 in arteriogenic and venogenic groups, compared to controls. 5 In animal experiments, there is shunting of blood from the subtunical space into the deep cavernosal circulation during both pelvic nerve and pharmacological stimulation. This shunting is more marked after pharmacological stimulation causing a greater drop in the subtunical oxygen tension in this group. 6 These changes may be responsible for inducing relative ischaemia and may have contributed to the formation of distal ®brosis in our patients.
A more careful titration of the dose of PGE1 may reduce the incidence of distal penile ®brosis. The minimally effective dose, which achieves an adequate erection for the minimum length of time needed for patient satisfaction, should be used. 
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